Literature DB >> 19502735

Effect of inducible expressed human cytomegalovirus immediate early 86 protein on cell apoptosis.

Zhiqiang Bai1, Ling Li, Bin Wang, Zhijun Liu, Haitao Wang, Zhiyong Yan, Dongmeng Qian, Shouyi Ding, Xuxia Song.   

Abstract

Human cytomegalovirus is a common human pathogen that can cause life-threatening disease under certain conditions. During infection of host cells, the virus expresses regulatory proteins such as IE72 and IE86 that are important for viral propagation. IE86 plays a critical role in the modulation of viral replication as well as host cell cycle control and apoptosis. In this study, a Tet-On system was used to quantify the effect of IE86 on apoptosis and p53 expression. Our results indicate that IE86 inhibits tumor necrosis factor (TNF)-alpha induced apoptosis and that the anti-apoptotic activity of this viral protein correlates with its expression levels. In addition, IE86 did not alter the mRNA level of p53. The system developed should provide a method for functional analysis of human cytomegalovirus (HCMV) IE86 protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502735     DOI: 10.1271/bbb.80722

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  The human cytomegalovirus major immediate-early proteins as antagonists of intrinsic and innate antiviral host responses.

Authors:  Christina Paulus; Michael Nevels
Journal:  Viruses       Date:  2009-11-05       Impact factor: 5.048

2.  Human cytomegalovirus inhibits apoptosis by regulating the activating transcription factor 5 signaling pathway in human malignant glioma cells.

Authors:  Tongmei Wang; Dongmeng Qian; Ming Hu; Ling Li; Li Zhang; Hao Chen; Rui Yang; Bin Wang
Journal:  Oncol Lett       Date:  2014-06-18       Impact factor: 2.967

3.  Mechanism of curcumin resistance to human cytomegalovirus in HELF cells.

Authors:  Yali Lv; Zhuoling An; Hui Chen; Zihui Wang; Lihong Liu
Journal:  BMC Complement Altern Med       Date:  2014-08-04       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.